Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Adrenocortical carcinoma
Results 1-14 of 14 for your search:
Start Over
Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
Status: Active
Phase: Phase III
Type: Treatment
Age: Over 18
Trial IDs: EudraCT 2007-007262-38, NCI-2014-00699, NCT00777244
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Ipilimumab and Hypofractionated Stereotactic Body Radiation Therapy in Treating Patients with Advanced Solid Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2013-0882, NCI-2015-00042, NCT02239900
Hyperthermic Intraperitoneal Cisplatin after Surgery in Treating Patients with Adrenocortical Cancer That Has Spread throughout the Abdomen
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 13-C-0114, NCI-2013-01590, P131214, NCT01833832
Pembrolizumab in Treating Patients with Adrenocortical Cancer That Cannot Be Removed by Surgery or is Metastatic
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15-286, NCI-2016-00224, NCT02673333
Nivolumab in Treating Patients with Metastatic Adrenocortical Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NU 15E01, STU00202153, NCI-2016-00194
Pembrolizumab in Treating Patients with Rare Solid Tumors That Cannot Be Removed by Surgery or are Metastatic
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-0948, NCI-2016-00545, NCT02721732
Iodine I 131 Monoclonal Antibody 8H9 in Treating Patients with Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 and over
Trial IDs: 09-090, NCI-2010-01242, NCT01099644
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: EMR 100070-001, NCI-2013-02214, 2013-002834-19, NCT01772004
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ATR-101-001, NCI-2013-02392, NCT01898715
Molecular Analysis of Tissue Samples from Patients with Endocrine Neoplasms
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 7 and over
Trial IDs: 09-C-0242, NCI-2015-01205, P09555, NCT01005654
Molecular Markers in Diagnosing Patients with Adrenal Neoplasms
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 18 to 90
Trial IDs: 11-C-0149, NCI-2015-01242, 313454, P11820, NCT01348698
Gathering Information and Samples from Individuals at High Risk of Cancer Due to Li-Fraumeni Syndrome or Li-Fraumeni-Like Syndrome, or Who Have Adrenal Cortex or Choroid Plexus Carcinoma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: 3 and over
Trial IDs: 11-C-0255, NCI-2015-01243, 315309, P11858, NCT01443468
Mifepristone in Treating Patients With Cancer
Status: Enrolling by invitation
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: INST 0817, NCI-2011-02682, NCT00832871
Start Over